JP2018510867A5 - - Google Patents

Download PDF

Info

Publication number
JP2018510867A5
JP2018510867A5 JP2017548109A JP2017548109A JP2018510867A5 JP 2018510867 A5 JP2018510867 A5 JP 2018510867A5 JP 2017548109 A JP2017548109 A JP 2017548109A JP 2017548109 A JP2017548109 A JP 2017548109A JP 2018510867 A5 JP2018510867 A5 JP 2018510867A5
Authority
JP
Japan
Prior art keywords
wash solution
chromatography
protein
matrix
antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017548109A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018510867A (ja
JP6807859B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2016/021984 external-priority patent/WO2016149088A1/en
Publication of JP2018510867A publication Critical patent/JP2018510867A/ja
Publication of JP2018510867A5 publication Critical patent/JP2018510867A5/ja
Application granted granted Critical
Publication of JP6807859B2 publication Critical patent/JP6807859B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017548109A 2015-03-13 2016-03-11 クロマトグラフィーにおける不純物を取り除くためのアルカリ洗浄の使用 Active JP6807859B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562132974P 2015-03-13 2015-03-13
US62/132,974 2015-03-13
PCT/US2016/021984 WO2016149088A1 (en) 2015-03-13 2016-03-11 Use of alkaline washes during chromatography to remove impurities

Publications (3)

Publication Number Publication Date
JP2018510867A JP2018510867A (ja) 2018-04-19
JP2018510867A5 true JP2018510867A5 (enExample) 2019-03-22
JP6807859B2 JP6807859B2 (ja) 2021-01-06

Family

ID=55699796

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017548109A Active JP6807859B2 (ja) 2015-03-13 2016-03-11 クロマトグラフィーにおける不純物を取り除くためのアルカリ洗浄の使用

Country Status (13)

Country Link
US (2) US10695693B2 (enExample)
EP (2) EP4194071A1 (enExample)
JP (1) JP6807859B2 (enExample)
KR (1) KR102490956B1 (enExample)
CN (1) CN107636005B (enExample)
AU (2) AU2016233557B2 (enExample)
BR (1) BR112017018365A2 (enExample)
CA (1) CA2978095C (enExample)
EA (1) EA035635B1 (enExample)
IL (1) IL254372B (enExample)
MX (1) MX395730B (enExample)
SG (2) SG10201908027QA (enExample)
WO (1) WO2016149088A1 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10738078B2 (en) * 2014-11-03 2020-08-11 Bristol-Myers Squibb Company Use of caprylic acid precipitation for protein purification
SG10201908027QA (en) 2015-03-13 2019-10-30 Bristol Myers Squibb Co Use of alkaline washes during chromatography to remove impurities
KR102586771B1 (ko) 2017-01-30 2023-10-11 리제너론 파마슈티칼스 인코포레이티드 크로마토그래피에서 바이오버든을 감소시키기 위한 조성물 및 방법
EP3810650A1 (en) * 2018-06-19 2021-04-28 Bristol-Myers Squibb Company Methods of purifying proteins using chromatography
US12152056B2 (en) * 2018-08-17 2024-11-26 Regeneron Pharmaceuticals, Inc. Method and chromatography system for determining amount and purity of a multimeric protein
KR102270048B1 (ko) * 2020-07-10 2021-06-28 주식회사 녹십자 바리셀라 조스터 바이러스 표면 단백질 항원의 생산 방법
EP3874276B1 (en) * 2018-10-31 2023-09-06 Regeneron Pharmaceuticals, Inc. Method and system of identifying and quantifying a protein
WO2020125757A1 (en) * 2018-12-21 2020-06-25 Wuxi Biologics (Shanghai) Co., Ltd. A method for improving aggregate removal by protein a chromatography
WO2020150328A1 (en) * 2019-01-16 2020-07-23 Regeneron Pharmaceuticals, Inc. Method and system of identifying and quantifying antibody fragmentation
CN109870428A (zh) * 2019-01-21 2019-06-11 江苏华泰疫苗工程技术研究有限公司 一种基于表面等离子共振技术的抗体定量检测方法
GB201904741D0 (en) * 2019-04-04 2019-05-22 Glaxosmithkline Ip Dev Ltd Novel process
EP4653865A3 (en) 2019-09-24 2026-02-18 Regeneron Pharmaceuticals, Inc. Systems and methods for chromatography use and regeneration
US20220396598A1 (en) * 2019-10-14 2022-12-15 Pierce Biotechnology, Inc. Peptide purification formulations and methods
BR112022019076A2 (pt) * 2020-03-27 2023-01-10 HaemaLogiX Ltd Composição e método
CN116348486A (zh) * 2020-10-02 2023-06-27 伊莱利利公司 在蛋白质纯化过程中降低宿主细胞蛋白质含量的方法
WO2025178923A1 (en) * 2024-02-20 2025-08-28 Exelixis, Inc. Methods for protein purification

Family Cites Families (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US5225539A (en) 1986-03-27 1993-07-06 Medical Research Council Recombinant altered antibodies and methods of making altered antibodies
US5190859A (en) * 1987-02-26 1993-03-02 Dana-Farber Cancer Institute, Inc. Purification of LFA-3
CA1326940C (en) * 1987-02-26 1994-02-08 Michael Dustin Purification of lfa-3
CA1323567C (en) * 1987-10-05 1993-10-26 Gene R. Nathans Method for purification of antibodies
US5476996A (en) 1988-06-14 1995-12-19 Lidak Pharmaceuticals Human immune system in non-human animal
US5223409A (en) 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
GB8823869D0 (en) 1988-10-12 1988-11-16 Medical Res Council Production of antibodies
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
ES2087997T3 (es) 1990-01-12 1996-08-01 Cell Genesys Inc Generacion de anticuerpos xenogenicos.
US6673986B1 (en) 1990-01-12 2004-01-06 Abgenix, Inc. Generation of xenogeneic antibodies
US6075181A (en) 1990-01-12 2000-06-13 Abgenix, Inc. Human antibodies derived from immunized xenomice
US6150584A (en) 1990-01-12 2000-11-21 Abgenix, Inc. Human antibodies derived from immunized xenomice
US5427908A (en) 1990-05-01 1995-06-27 Affymax Technologies N.V. Recombinant library screening methods
US6172197B1 (en) 1991-07-10 2001-01-09 Medical Research Council Methods for producing members of specific binding pairs
GB9015198D0 (en) 1990-07-10 1990-08-29 Brien Caroline J O Binding substance
US5874299A (en) 1990-08-29 1999-02-23 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
US5770429A (en) 1990-08-29 1998-06-23 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
US5545806A (en) 1990-08-29 1996-08-13 Genpharm International, Inc. Ransgenic non-human animals for producing heterologous antibodies
US5877397A (en) 1990-08-29 1999-03-02 Genpharm International Inc. Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
US6300129B1 (en) 1990-08-29 2001-10-09 Genpharm International Transgenic non-human animals for producing heterologous antibodies
US5661016A (en) 1990-08-29 1997-08-26 Genpharm International Inc. Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
ES2108048T3 (es) 1990-08-29 1997-12-16 Genpharm Int Produccion y utilizacion de animales inferiores transgenicos capaces de producir anticuerpos heterologos.
US5814318A (en) 1990-08-29 1998-09-29 Genpharm International Inc. Transgenic non-human animals for producing heterologous antibodies
US5625126A (en) 1990-08-29 1997-04-29 Genpharm International, Inc. Transgenic non-human animals for producing heterologous antibodies
US5789650A (en) 1990-08-29 1998-08-04 Genpharm International, Inc. Transgenic non-human animals for producing heterologous antibodies
US5633425A (en) 1990-08-29 1997-05-27 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
US6255458B1 (en) 1990-08-29 2001-07-03 Genpharm International High affinity human antibodies and human antibodies against digoxin
ATE463573T1 (de) 1991-12-02 2010-04-15 Medimmune Ltd Herstellung von autoantikörpern auf phagenoberflächen ausgehend von antikörpersegmentbibliotheken
EP0746609A4 (en) 1991-12-17 1997-12-17 Genpharm Int NON-HUMAN TRANSGENIC ANIMALS CAPABLE OF PRODUCING HETEROLOGOUS ANTIBODIES
EP1005870B1 (en) 1992-11-13 2009-01-21 Biogen Idec Inc. Therapeutic application of chimeric antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma
JPH08509612A (ja) 1993-04-26 1996-10-15 ジェンファーム インターナショナル インコーポレイテッド 異種抗体を産生することができるトランスジェニック非ヒト動物
US5534615A (en) 1994-04-25 1996-07-09 Genentech, Inc. Cardiac hypertrophy factor and uses therefor
ES2292682T3 (es) * 1998-05-06 2008-03-16 Genentech, Inc. Purificacion de anticuerpos mediante cromatografia de intercambio ionico.
NZ517202A (en) 1999-08-24 2004-05-28 Medarex Inc Human CTLA-4 antibodies and their uses
JP3523245B1 (ja) 2000-11-30 2004-04-26 メダレックス,インコーポレーテッド ヒト抗体作製用トランスジェニック染色体導入齧歯動物
ATE417858T1 (de) 2002-02-05 2009-01-15 Genentech Inc Proteinaufreinigung
US7763706B1 (en) * 2003-07-17 2010-07-27 Campina B.V. Arginine/lysine-enriched peptides
PT1678208E (pt) * 2003-10-27 2013-07-10 Wyeth Llc Remoção de agregados de elevado peso molecular utilizando cromatografia de hidroxiapatite
ES2342100T3 (es) * 2005-04-26 2010-07-01 Sandoz Ag Ligandos de afinidad.
US8263750B2 (en) * 2006-03-16 2012-09-11 Amgen Inc. Method for purifying a protein using protein-A affinity chromatography using an intermediate wash step
FI2061803T4 (fi) * 2006-08-28 2023-03-14 Process for the purification of fc-containing proteins
CL2007002615A1 (es) 2006-09-08 2008-04-18 Wyeth Corp Metodos para aislar o purificar un producto que comprende poner el producto enlazado en contacto con al menos una solucion de lavado que comprende arginina y luego eluir el producto; y dicho producto.
BRPI0817182A2 (pt) * 2007-10-30 2015-03-17 Genentech Inc Método para purificar um anticorpo e composições
TWI610936B (zh) * 2008-10-20 2018-01-11 艾伯維有限公司 使用蛋白質a親和性層析進行抗體之分離及純化
CA2784278C (en) 2009-12-18 2019-02-26 Novartis Ag Wash solution and method for affinity chromatography
JP2012001462A (ja) * 2010-06-15 2012-01-05 Kaneka Corp 抗体精製用カラム
JP6366502B2 (ja) 2011-06-01 2018-08-01 ノバルティス アーゲー アフィニティクロマトグラフィーのための、洗浄溶液および方法
AR096713A1 (es) * 2013-06-25 2016-01-27 Cadila Healthcare Ltd Proceso de purificación para anticuerpos monoclonales
US9758578B2 (en) * 2013-12-26 2017-09-12 Mitsubishi Tanabe Pharma Corporation Human anti-IL-33 neutralizing monoclonal antibody
WO2016031932A1 (ja) 2014-08-27 2016-03-03 田辺三菱製薬株式会社 アルカリ洗浄によるFc領域を有するタンパク質の製造方法
SG10201908027QA (en) 2015-03-13 2019-10-30 Bristol Myers Squibb Co Use of alkaline washes during chromatography to remove impurities

Similar Documents

Publication Publication Date Title
JP2018510867A5 (enExample)
US10053489B2 (en) Method for purifying antibody
JP2015537212A5 (enExample)
JP2017521389A5 (enExample)
ES2670827T3 (es) Proceso para la purificación del factor estimulador de colonias de granulocitos, G-CSF
US8093364B2 (en) Enhanced purification of antibodies and antibody fragments by apatite chromatography
JP6092892B2 (ja) 抗体の精製方法
RU2015122726A (ru) ОПОСРЕДОВАННАЯ ИОННОЙ СИЛОЙ рН-ГРАДИЕНТНАЯ ИОНООБМЕННАЯ ХРОМАТОГРАФИЯ
US10246484B2 (en) Method for purifying recombinant protein
US10370408B2 (en) Method for purification of a DNase or RNase protein from a sample
RU2017100005A (ru) Способ очистки белка слияния
JP2014532718A5 (enExample)
JP2016530533A5 (enExample)
HRP20171095T4 (hr) Postupci pročišćavanja polipeptida
ES2112865T3 (es) Anticuerpos igg purificados.
RU2014130017A (ru) Способы повышения эффективности этапов очистки белка, находящихся ниже по потоку, с использованием мембранной ионообменной хроматографии
Bolton et al. Inactivation of viruses using novel protein A wash buffers
RU2018121653A (ru) Улучшенное разделение белков при ионообменной хроматографии
RU2018121657A (ru) ПРОТИВОПОЛОЖНЫЕ ГРАДИЕНТЫ pH-СОЛЬ ДЛЯ УЛУЧШЕННОГО РАЗДЕЛЕНИЯ БЕЛКОВ
HRP20211026T1 (hr) Metoda za smanjenje proteina stanice domaćina u afinitetnoj kromatografiji
JP2014521364A5 (enExample)
CN104136121A (zh) 减少离子交换色谱中的pH漂移
JP2016529489A5 (enExample)
Li et al. Capture and purification of an untagged nanobody by mixed weak cation chromatography and cation exchange chromatography
Rajak et al. Purification of monoclonal antibodies, IgG1, from cell culture supernatant by use of metal chelate convective interaction media monolithic columns